Total Wrist Arthroplasty Versus Wrist Fusion: Utilization and Complication Rates as Reported by ABOS Part II Candidates

Hinds, Richard M.; Capo, John T.; Rizzo, Marco; Roberson, James R.; Gottschalk, Michael B.

doi:10.1177/1558944716668846

Cited by 11 publications

(11 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, the Maestro TM WRS has proven to be useful as well as salvage procedure of a failed previously performed PWF, and in single cases as early treatment option for highly comminuted distal radius fracture in selected older and elderly patients [24,25]. Furthermore, recent evidence suggests that the complication rate of TWA does not differ statistically significant in comparison to patients undergoing a TWF [26,27]. Till 2014, implant survival with the third TWA generation types was reported to be 90 to 100% at 5 years in most series, but it declines from 5 to 8 years [9].…”

mentioning

confidence: 99%

“…Hence, a TWA [28]. In the past, TWA was almost exclusively used in older patients with rheumatoid arthritis because of their low-demand lifestyle, whereas patients with post-traumatic WJOA are typically young and active [22][23][24][25][26][27][28][29][30][31][32]. However, there is a trend in the literature towards the increasing expansion of the indication also for selected younger patients aged 31 years or younger with post-traumatic WJOA associated with good bone stock (including the Maestro TM WRS), and high claims in their activities of daily living are not always considered as contraindication [6,17,23,33,[35][36][37][38][39][40].…”

mentioning

confidence: 99%

See 1 more Smart Citation

A critical appraisal to the decision by the company Zimmer Biomet to withdraw the MaestroTM Wrist Reconstructive System from the marketplace

Schmidt¹

2018

Trauma Emerg Care

View full text Add to dashboard Cite

Note by the author: 75% of 104 Scientific References related to TWA are not older than 10 years, and 81% of them are not older than 5 years. Case presentationThis is to inform the community of all Orthopaedic and Hand Surgeons around the world who are interested in Total Wrist Arthroplasty (TWA) about the official decision by the European and German Branches (Winterthur, Switzerland and Freiburg i. Breisgau, Germany) of the company for distribution (Zimmer Biomet Holdings Inc., Warsaw, Indiana/USA) for the Maestro TM Wrist Reconstructive System (WRS, insertion of the carpal plate with variable or fixed locking screws) (Figure 1A-C). Recently, the company informed the author on February 26., 2018 that they have definitively withdrawn the Maestro TM WRS from the marketplace here in Germany, and this decision will be extended in 2018 for all other countries worldwide if the CE certification is finished in these countries in 2018 as well. The company officially wrote that the cause for its withdrawal is that as follows: The Maestro TM WRS is approved only for its cemented use by the US Food and Drug Administration (FDA) and there are no publications in the literature worldwide on favorable results with its cemented use, and so, it cannot be guaranteed the surveillance of this implant by the company if it inserted in a non-cemented manner (i.e. "off-label" use).

show abstract

mentioning

confidence: 99%

mentioning

confidence: 99%

A critical appraisal to the decision by the company Zimmer Biomet to withdraw the MaestroTM Wrist Reconstructive System from the marketplace

Schmidt¹

2018

Trauma Emerg Care

View full text Add to dashboard Cite

show abstract

“…These findings closely parallel the demographics of TWA reported in other large analyses to include American Board of Orthopaedic Surgeon candidate database and the National Inpatient Summary database. 4,23 In addition to the similar demographics between the large reported series of TWA, these cohorts also have similarly low compilation rates. The studied NSQIP database identified no postoperative complications in the acute 30-day setting even in patients with known preoperative comorbid factors (smoking, 24 chronic steroid use, 25 and diabetes 26 ) that have been associated with an increased risk of wound complications.…”

Section: Discussionmentioning

confidence: 92%

“…3 Arthroplasty is specifically indicated for inflammatory arthritis, posttraumatic arthritis, and osteoarthritis. 2,[4][5][6] Traditionally these conditions were treated with arthrodesis, 7 however, arthroplasty both alleviates a painful deformity while retaining motion through the radiocarpal joint.…”

mentioning

confidence: 99%

Acute Complications in Total Wrist Arthroplasty: A National Surgical Quality Improvement Program Review

et al. 2019

View full text Add to dashboard Cite

Background The study sought to assess the patient-based variables, surgical risk factors, and postoperative conditions associated with readmission after total wrist arthroplasty (TWA). Materials and Methods All patients undergoing TWA were identified from the National Surgical Quality Improvement Program dataset from 2005 to 2016. Patient demographics, medical comorbidities, surgical characteristics, and outcomes were examined to isolate predictors for readmission within 30 days postoperatively. Results A total of 57 patients were identified to have undergone TWA. The average patients were 62.3 (13.8) years old, female (57.7%), and most were treated in the outpatient setting (67.3%). Comorbid conditions included smoking (17.3%), diabetes (15.4%), and chronic steroid therapy (15.4%). No complications were identified in the 30-day postoperative period. There was a trend for increasing utilization of TWA over the years included. Conclusion TWA is a safe procedure with low complication rates in the acute postoperative period. Increasing utilization is likely a result of improved outcomes and cost-effectiveness of TWA. Level of Evidence This is a Level II, prognostic study.

show abstract

“…Approximately 3000 procedures were performed in the USA in 2015 33. Similar to the ankle joint, wrist arthrodesis is the most frequently recommended treatment,34 with only approximately 1000 total wrist arthroplasty procedures performed annually in the USA 35…”

Section: Introductionmentioning

confidence: 99%

Relationship between hospital or surgeon volume and outcomes in joint arthroplasty: protocol for a suite of systematic reviews and dose–response meta-analyses

Wu¹,

Liu

Sun

et al. 2018

BMJ Open

View full text Add to dashboard Cite

IntroductionJoint arthroplasty is a particularly complex orthopaedic surgical procedure performed on joints, including the hip, knee, shoulder, ankle, elbow, wrist and even digit joints. Increasing evidence from volume–outcomes research supports the finding that patients undergoing joint arthroplasty in high-volume hospitals or by high-volume surgeons achieve better outcomes, and minimum case load requirements have been established in some areas. However, the relationships between hospital/surgeon volume and outcomes in patients undergoing arthroplasty are not fully understood. Furthermore, whether elective arthroplasty should be restricted to high-volume hospitals or surgeons remains in dispute, and little is known regarding where the thresholds should be set for different types of joint arthroplasties.Methods and analysesThis is a protocol for a suite of systematic reviews and dose–response meta-analyses, which will be amended and updated in conjunction with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. Electronic databases, including PubMed and Embase, will be searched for observational studies examining the relationship between the hospital or surgeon volume and clinical outcomes in adult patients undergoing primary or revision of joint arthroplasty. We will use records management software for study selection and a predefined standardised file for data extraction and management. Quality will be assessed using the Newcastle-Ottawa Scale, and the meta-analysis, subgroup analysis and sensitivity analysis will be performed using Stata statistical software. Once the volume–outcome relationships are established, we will examine the potential non-linear relationships between hospital/surgeon volume and outcomes and detect whether thresholds or turning points exist.Ethics and disseminationEthical approval is not required, because these studies are based on aggregated published data. The results of this suite of systematic reviews and meta-analyses will be submitted to peer-reviewed journals for publication.PROSPERO registration numberCRD42017056639.

show abstract

Total Wrist Arthroplasty Versus Wrist Fusion: Utilization and Complication Rates as Reported by ABOS Part II Candidates

Abstract: Utilization of both TWA and WF has remained unchanged among emerging career orthopedic surgeons. Although WF is performed nearly 5 times more frequently than TWA, our short-term findings suggest that TWA compares favorably with WF.

Cited by 11 publications

References 33 publications

A critical appraisal to the decision by the company Zimmer Biomet to withdraw the MaestroTM Wrist Reconstructive System from the marketplace

A critical appraisal to the decision by the company Zimmer Biomet to withdraw the MaestroTM Wrist Reconstructive System from the marketplace

Acute Complications in Total Wrist Arthroplasty: A National Surgical Quality Improvement Program Review

Relationship between hospital or surgeon volume and outcomes in joint arthroplasty: protocol for a suite of systematic reviews and dose–response meta-analyses

Contact Info

Product

Resources

About